243 related articles for article (PubMed ID: 11027594)
21. Antigenic mixture of synthetic peptides for the immunodiagnosis of HTLV I/II infection.
Bocalandro YM; Marin MH; Vallejo RA; Peña LP; León CS; Martínez GR; Tanty CR; Clarke DH; Velázquez SB
J Immunoassay Immunochem; 2004; 25(3):205-14. PubMed ID: 15461383
[TBL] [Abstract][Full Text] [Related]
22. Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice.
Schönbach C; Nokihara K; Bangham CR; Kariyone A; Karaki S; Shida H; Takatsu K; Egawa K; Wiesmüller KH; Takiguchi M
Virology; 1996 Dec; 226(1):102-12. PubMed ID: 8941327
[TBL] [Abstract][Full Text] [Related]
23. Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.
Noraz N; Benichou S; Madaule P; Tiollais P; Vernant JC; Desgranges C
Virology; 1993 Mar; 193(1):80-8. PubMed ID: 7679862
[TBL] [Abstract][Full Text] [Related]
24. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
Tallet B; Astier-Gin T; Moynet D; Londos-Gagliardi D; Guillemain B
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):337-48. PubMed ID: 11242520
[TBL] [Abstract][Full Text] [Related]
25. [Comparative analysis of the sequenced fragment of the Macaca arctoides STLV-1 env gene encoding the immunodominant region gp46 and the similar fragments in HTLV-1 (ATK) and STLV-1 from various primate species].
Chikobava MG; Iakovleva LA; Indzhiia LV; Lapin BA
Biull Eksp Biol Med; 1997 Jul; 124(7):92-6. PubMed ID: 9303743
[No Abstract] [Full Text] [Related]
26. Identification of a novel neutralization epitope on envelope gp46 antigen of human T-cell-leukemia virus-type-II (HTLV-II).
Tanaka Y; Tanaka R; Hoshino H
Int J Cancer; 1994 Dec; 59(5):655-60. PubMed ID: 7525496
[TBL] [Abstract][Full Text] [Related]
27. Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.
Palker TJ; Singer KH; Vahlne A
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):10-9. PubMed ID: 8528727
[TBL] [Abstract][Full Text] [Related]
28. Antibodies directed against a variable and neutralizable region of the HTLV-I envelope surface glycoprotein.
Londos-Gagliardi D; Armengaud MH; Freund F; Dalibart R; Moze E; Huet S; Legrand E; Guillemain BJ
Leukemia; 1997 Apr; 11 Suppl 3():38-41. PubMed ID: 9209290
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.
Londos-Gagliardi D; Dalibart R; Geoffre S; Dalbon P; Pouliquen JF; Georges-Courbot MC; Sainte-Foie S; Hajjar C; Georges AJ; Moreau JP; Guillemain B
AIDS Res Hum Retroviruses; 1996 Jul; 12(10):941-50. PubMed ID: 8798979
[TBL] [Abstract][Full Text] [Related]
30. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105
[TBL] [Abstract][Full Text] [Related]
31. Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I.
Edouard E; Legrand E; Astier-Gin T; Dalibart R; Geoffre S; Dalbon P; Guillemain B; Londos-Gagliardi D
Leukemia; 1994 Apr; 8 Suppl 1():S60-4. PubMed ID: 7512182
[TBL] [Abstract][Full Text] [Related]
32. Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.
Rudolph DL; Yee J; Palker T; Coligan JE; Lal RB
Res Virol; 1993; 144(3):193-9. PubMed ID: 8395074
[TBL] [Abstract][Full Text] [Related]
33. [Cross reactivity and amino acid structural homology of immunodominant peptide fragments of structural viruses from the human retroviruses HTLV-I, HTLV-II, HIV-1, and HIV-2].
Rasuli AM; Rasuli ShM; Klepikov NN; Andreev SM; Meshcheriakova DV; Tarasova SO; Seniuta NB; Syrtsev AV; Gurtsevich VE
Mol Biol (Mosk); 1995; 29(1):225-38. PubMed ID: 7723762
[TBL] [Abstract][Full Text] [Related]
34. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
[TBL] [Abstract][Full Text] [Related]
35. Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal anti-env antibodies correlate with protection in non-breast-fed children.
Hino S; Katamine S; Miyamoto T; Doi H; Tsuji Y; Yamabe T; Kaplan JE; Rudolph DL; Lal RB
J Clin Invest; 1995 Jun; 95(6):2920-5. PubMed ID: 7769134
[TBL] [Abstract][Full Text] [Related]
36. Probing the conformation of the human T-lymphotropic virus I envelope protein complex with monoclonal antibodies.
Carrington CV; Paul N; Cordell J; Schulz TF
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2025-9. PubMed ID: 8810999
[TBL] [Abstract][Full Text] [Related]
37. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
Zhang XQ; Yang L; Ho DD; Kuritzkes DR; Chen IS; Ching WT; Chen YM; Schooley RT
J Infect Dis; 1992 May; 165(5):805-12. PubMed ID: 1373751
[TBL] [Abstract][Full Text] [Related]
38. Recognition by human sera of a variable region of the surface glycoprotein of HTLV-I.
Edouard E; Londos-Gagliardi D; Busetta B; Geoffre S; Dalbon P; Moreau JP; Guillemain B
Leukemia; 1994 Apr; 8 Suppl 1():S65-7. PubMed ID: 8152306
[TBL] [Abstract][Full Text] [Related]
39. Structural and immunogenicity analysis of chimeric B-cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV-1.
Sundaram R; Beebe M; Kaumaya PT
J Pept Res; 2004 Feb; 63(2):132-40. PubMed ID: 15009534
[TBL] [Abstract][Full Text] [Related]
40. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
